Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Naked Truth - Big Kahuna a Myth -- Ignore unavailable to you. Want to Upgrade?

To: pater tenebrarum who wrote (71355)	10/22/1999 8:55:00 PM
From: re3	Read Replies (1) \| Respond to of 86076

yeah, i know that sort of thinking, i'd rather own the mrk's or wla's of the world, if there is mega inflation, they'd raise prices... at some point, a pentium something or other will be sufficient...people won't upgrade like they have in the past with pc's... loouie r made fun of gold, and cisco was called a buy...pls resume normal duties... ike

To: pater tenebrarum who wrote (71355)	10/22/1999 8:58:00 PM
From: BGR	Read Replies (3) \| Respond to of 86076

Good point, Heinz!? Man, and I thought that you are better informed than most. What about the x86 architecture, for starters? Goodness, MSFT, the most well known of the s/w comapnies has everything proprietory. You think that the SunOS-SOLARIS architecture is for all to freely copy w/o paying license fees? In fact, drug patents expire after 20 years usually, of which Phases 1 trough 3 of drug development take up to 10 years (though this is dropping fast because of technology). In particular, for s/w companies, everything is propietory. Well, 10 years outdated s/w is worth nothing anyway, so even the problem of copyright expiration doesn't apply. On top, most s/w companies have increasing return based business models w/ little capital outlay. Drug comapnies have these capital intensive production lines to keep busy even when no new ideas are in the pipeline. And you think that Ike's position, that drug companies deserve higher premia, is a good one? No wonder that the market disagrees wth you. Sorry if I sound harsh, but this really takes the cake of all the ludicrous things posted in this thread, half of them by Luc.